Overnutrition, Hyperinsulinemia and Ectopic Fat: It Is Time for A Paradigm Shift in the Management of Type 2 Diabetes

被引:9
|
作者
Janssen, Joseph A. M. J. L. [1 ]
机构
[1] Erasmus MC, Dept Internal Med, NL-3015 GD Rotterdam, Netherlands
关键词
hyperinsulinemia; overnutrition; ultra-processed foods; insulin resistance; hepatic insulin clearance and insulin resistance; prediabetes; type; 2; diabetes; bariatric surgery; VLCD diets; caloric restriction; prevention; personal fat hypothesis; ectopic fat; remission of type 2 diabetes; tirzepatide; HEPATIC INSULIN-CLEARANCE; PULSATILE INSULIN; BARIATRIC SURGERY; PLASMA-GLUCOSE; METABOLIC SYNDROME; WEIGHT-LOSS; LIVER FAT; INTRAVENOUS GLUCOSE; RISK-FACTORS; SHORT-TERM;
D O I
10.3390/ijms25105488
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The worldwide incidence of prediabetes/type 2 has continued to rise the last 40 years. In the same period, the mean daily energy intake has increased, and the quality of food has significantly changed. The chronic exposure of pancreatic beta-cells to calorie excess (excessive energy intake) and food additives may increase pancreatic insulin secretion, decrease insulin pulses and/or reduce hepatic insulin clearance, thereby causing chronic hyperinsulinemia and peripheral insulin resistance. Chronic calorie excess and hyperinsulinemia may promote lipogenesis, inhibit lipolysis and increase lipid storage in adipocytes. In addition, calorie excess and hyperinsulinemia can induce insulin resistance and contribute to progressive and excessive ectopic fat accumulation in the liver and pancreas by the conversion of excess calories into fat. The personal fat threshold hypothesis proposes that in susceptible individuals, excessive ectopic fat accumulation may eventually lead to hepatic insulin receptor resistance, the loss of pancreatic insulin secretion, hyperglycemia and the development of frank type 2 diabetes. Thus, type 2 diabetes seems (partly) to be caused by hyperinsulinemia-induced excess ectopic fat accumulation in the liver and pancreas. Increasing evidence further shows that interventions (hypocaloric diet and/or bariatric surgery), which remove ectopic fat in the liver and pancreas by introducing a negative energy balance, can normalize insulin secretion and glucose tolerance and induce the sustained biochemical remission of type 2 diabetes. This pathophysiological insight may have major implications and may cause a paradigm shift in the management of type 2 diabetes: avoiding/reducing ectopic fat accumulation in the liver and pancreas may both be essential to prevent and cure type 2 diabetes.
引用
收藏
页数:24
相关论文
共 50 条
  • [41] A double-blind, placebo-controlled, randomised trial to assess the effect of liraglutide on ectopic fat accumulation in South Asian type 2 diabetes patients
    van Eyk, Huub J.
    Paiman, Elisabeth H. M.
    Bizino, Maurice B.
    de Heer, Paul
    Geelhoed-Duijvestijn, Petronella H.
    Kharagjitsingh, Aan V.
    Smit, Johannes W. A.
    Lamb, Hildo J.
    Rensen, Patrick C. N.
    Jazet, Ingrid M.
    CARDIOVASCULAR DIABETOLOGY, 2019, 18 (1)
  • [42] Developmental overnutrition and obesity and type 2 diabetes in offspring
    Wei Perng
    Emily Oken
    Dana Dabelea
    Diabetologia, 2019, 62 : 1779 - 1788
  • [43] Interventions to Preserve Beta-Cell Function in the Management and Prevention of Type 2 Diabetes
    Page, Kathleen A.
    Reisman, Tamar
    CURRENT DIABETES REPORTS, 2013, 13 (02) : 252 - 260
  • [44] The association between ectopic fat in the pancreas and subclinical atherosclerosis in type 2 diabetes
    Kim, Mee Kyoung
    Chun, Hyun Ji
    Park, Jin Hee
    Yeo, Dong Myung
    Baek, Ki-Hyun
    Song, Ki-Ho
    Chung, Dong Jin
    Kwon, Hyuk-Sang
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 (03) : 590 - 596
  • [45] Ectopic and Visceral Fat Deposition in Lean and Obese Patients With Type 2 Diabetes
    Levelt, Eylem
    Pavlides, Michael
    Banerjee, Rajarshi
    Mahmod, Masliza
    Kelly, Catherine
    Sellwood, Joanna
    Ariga, Rina
    Thomas, Sheena
    Francis, Jane
    Rodgers, Christopher
    Clarke, William
    Sabharwal, Nikant
    Antoniades, Charalambos
    Schneider, Jurgen
    Robson, Matthew
    Clarke, Kieran
    Karamitsos, Theodoros
    Rider, Oliver
    Neubauer, Stefan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (01) : 53 - 63
  • [46] Modeling type 2 diabetes in rats using high fat diet and streptozotocin
    Skovso, Sos
    JOURNAL OF DIABETES INVESTIGATION, 2014, 5 (04) : 349 - 358
  • [47] Polyagonists in Type 2 Diabetes Management
    Dissanayake, H. A.
    Somasundaram, N. P.
    CURRENT DIABETES REPORTS, 2024, 24 (01) : 1 - 12
  • [48] Management of Type 2 Diabetes and Gestational Diabetes in Pregnancy
    Boinpally, Tara
    Jovanovic, Lois
    MOUNT SINAI JOURNAL OF MEDICINE, 2009, 76 (03): : 269 - 280
  • [49] Role of oxidative stress and inflammation in the origin of type 2 diabetes - a paradigm shift
    Pillarisetti, S
    Saxena, U
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2004, 8 (05) : 401 - 408
  • [50] Management of Dyslipidemias in the Presence of the Metabolic Syndrome or Type 2 Diabetes
    Matikainen, Niina
    Taskinen, Marja-Riitta
    CURRENT CARDIOLOGY REPORTS, 2012, 14 (06) : 721 - 731